1. Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe
    E.J. Blok et al, 2018, Cancer Treatment Reviews CrossRef
  2. Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models
    Ellen G. Engelhardt et al, 2014, Journal of Clinical Oncology CrossRef
  3. Effect of Okinawa Propolis on PAK1 Activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells
    Nozomi Taira et al, 2016, Journal of Agricultural and Food Chemistry CrossRef
  4. Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen et al, 2012, Annals of Surgical Oncology CrossRef
  5. Validación y aplicación clínica de MammaPrint ® en pacientes con cáncer de mama
    Ernesto Roberto Sánchez-Forgach et al, 2017, Cirugía y Cirujanos CrossRef
  6. GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW
    Alison Scope et al, 2017, International Journal of Technology Assessment in Health Care CrossRef
  7. Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward “precision” cancer therapy
    BM Turner et al, 2017, Biotechnic & Histochemistry CrossRef
  8. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology
    Wei Hou et al, 2020, European Journal of Medicinal Chemistry CrossRef
  9. MammaPrint Genomic Assay Providing Prognostic Information in Early Breast Cancer: 10-Year Follow-Up From a Retrospective German Breast Cancer Registry Analysis
    C Jackisch et al, 2024, EMJ Oncology CrossRef
  10. Poly(d,l lactic-co-glycolic) membranes seeded with human adipose stem cells for dermal substitute
    Adriana Cristina Motta et al, 2021, Polymer Bulletin CrossRef
  11. MammaPrint® 10-Year Follow Up Results from a German Breast Cancer Cohort Study
    C. Jackisch et al, 2022, EMJ Oncology CrossRef
  12. Validation and clinical application of MammaPrint ® in patients with breast cancer
    Ernesto Roberto Sánchez-Forgach et al, 2017, Cirugía y Cirujanos (English Edition) CrossRef